175 related articles for article (PubMed ID: 1532939)
1. Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis.
Spiteri MA; Clarke SW; Poulter LW
Eur Respir J; 1992 Apr; 5(4):394-403. PubMed ID: 1532939
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.
Spiteri MA; Clarke SW; Poulter LW
Clin Exp Immunol; 1988 Dec; 74(3):359-64. PubMed ID: 2466589
[TBL] [Abstract][Full Text] [Related]
3. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage.
Spiteri MA; Clarke SW; Poulter LW
Eur Respir J; 1992 Jun; 5(6):717-26. PubMed ID: 1628729
[TBL] [Abstract][Full Text] [Related]
4. The macrophage in sarcoid granuloma formation.
Spiteri MA; Poulter LW; Geraint-James D
Sarcoidosis; 1989 Oct; 6 Suppl 1():12-4. PubMed ID: 2623371
[TBL] [Abstract][Full Text] [Related]
5. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L.
Nicod LP; Isler P
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):91-6. PubMed ID: 9224214
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis.
Melis M; Gjomarkaj M; Pace E; Malizia G; Spatafora M
Chest; 1991 Oct; 100(4):910-6. PubMed ID: 1680610
[TBL] [Abstract][Full Text] [Related]
7. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage.
Stríz I; Wang YM; Svarcová I; Trnka L; Sorg C; Costabel U
Eur Respir J; 1993 Oct; 6(9):1287-94. PubMed ID: 7904572
[TBL] [Abstract][Full Text] [Related]
8. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells.
Schaberg T; Rau M; Stephan H; Lode H
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1507-13. PubMed ID: 8099261
[TBL] [Abstract][Full Text] [Related]
9. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
[TBL] [Abstract][Full Text] [Related]
10. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
[TBL] [Abstract][Full Text] [Related]
11. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
Hunninghake GW
Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
[TBL] [Abstract][Full Text] [Related]
12. [Proliferation of alveolar macrophages in pulmonary sarcoidosis correlates with markers of lymphocyte activity in bronchoalveolar lavage fluid].
Barth J; Kreipe H; Kiemle-Kallee J; Radzun HJ; Petermann W
Pneumologie; 1990 Feb; 44 Suppl 1():224-5. PubMed ID: 1973297
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
Lem VM; Lipscomb MF; Weissler JC; Nunez G; Ball EJ; Stastny P; Toews GB
J Immunol; 1985 Sep; 135(3):1766-71. PubMed ID: 3874905
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
[TBL] [Abstract][Full Text] [Related]
15. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
16. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.
Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J
Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural localization of anionic sites and lectin-binding sites in sarcoid human alveolar macrophages during interaction with T-lymphocytes.
Thole AA; Stumbo AC; Costa CH; Milward G; Porto LC; Carvalho L
J Submicrosc Cytol Pathol; 1999 Jan; 31(1):131-5. PubMed ID: 10363360
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of anti-T-lymphocyte antibodies in sarcoidosis.
Spurzem JR; Saltini C; Crystal RG
Am Rev Respir Dis; 1988 Mar; 137(3):600-5. PubMed ID: 2964216
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
[TBL] [Abstract][Full Text] [Related]
20. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
Cassatella MA; Berton G; Agostini C; Zambello R; Trentin L; Cipriani A; Semenzato G
Immunology; 1989 Mar; 66(3):451-8. PubMed ID: 2539325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
